Search This Blog

Tuesday, July 27, 2010

Agilent. Cytogenomics Meeting, Chicago


INVITED SPEAKER


Nallasivam Palanisamy, PhD
8/4/2010

“Transcriptome sequencing to detect gene fusions in cancer”.


Agilent Cytogenomics User Group Meeting, Hyatt Regency O’Hare, August 3-4, Chicago, IL. 


share what you have.........

Sunday, July 25, 2010

Meeting with Dr. Abdul Kalam, The 11th President of India (2002-2007)

Abdul Kalam - A true Inspirational and Visionary Leader of Modern India

 
a source of inspiration.........

Friday, July 23, 2010

Member, Michigan Center for Translational Pathology (MCTP)

Nallasivam Palanisamy

Research Interests

 Discovery and characterization of gene fusions in cancer and understanding their role in carcinogenesis from a translational research perspective.

 Development of diagnostic reagents based on fluorescence in situ hybridization method (FISH) for recurrent chromosome translocations in cancer.

 Application of new high throughput technologies in genome research towards understanding the cancer genome and transcriptome.

RAF translocations expand cancer targets

RAF translocations expand cancer targets

Chromosomal translocations can promote cancers by eliciting the expression of fusion genes with oncogenic activity. The identification of translocations affecting RAF genes in prostate and gastric cancers and melanoma provides compelling evidence for the key role of RAF signaling in a subset of these cancers and suggests possible new avenues for personalized cancer therapy. 


be passionate and determined..........

Search This Blog